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using data from the European Prospective Investigation 
into Cancer and Nutrition cohort of 477,206 participants 
from 10 European countries.
Methods After 11.4 years of follow-up, 191 HCC, 66 
IHBC and 236 GBTC cases were identified. Hazard ratios 
and 95 % confidence intervals (HR; 95 % CI) were esti-
mated with Cox regression models with multivariable 
adjustment (baseline total energy intake, alcohol consump-
tion and intake pattern, body mass index, physical activity, 
Abstract 
Purpose The aim of the study was to assess associations 
between intake of combined soft drinks (sugar sweetened 
and artificially sweetened) and fruit and vegetable juices 
and the risk of hepatocellular carcinoma (HCC), intrahe-
patic bile duct (IHBC) and biliary tract cancers (GBTC) 
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level of educational attainment and self-reported diabetes 
status).
Results No risk associations were observed for IHBC or 
GBTC. Combined soft drinks consumption of >6 servings/
week was positively associated with HCC risk: HR 1.83; 
95 % CI 1.11–3.02, ptrend = 0.01 versus non-consumers. In 
sub-group analyses available for 91 % of the cohort arti-
ficially sweetened soft drinks increased HCC risk by 6 % 
per 1 serving increment (HR 1.06, 95 % CI 1.03–1.09, 
ncases = 101); for sugar-sweetened soft drinks, this associa-
tion was null (HR 1.00, 95 % CI 0.95–1.06; ncases = 127, 
pheterogeneity = 0.07). Juice consumption was not associ-
ated with HCC risk, except at very low intakes (<1 serv-
ing/week: HR 0.60; 95 % CI 0.38–0.95; ptrend = 0.02 vs. 
non-consumers).
Conclusions Daily intake of combined soft drinks is posi-
tively associated with HCC, but a differential association 
between sugar and artificially sweetened cannot be dis-
counted. This study provides some insight into possible 
associations of HCC with sugary drinks intake. Further 
exploration in other settings is required.
Keywords Hepatocellular carcinoma · Biliary tract 
cancers · Soft drink · Fruit and vegetable juice · Prospective 
cohort
Abbreviations
HCC  Hepatocellular carcinoma
IHBC  Intrahepatic bile duct
HBV  Hepatitis B
HCV  Hepatitis C
T2D  Type 2 diabetes
NAFLD  Non-alcoholic fatty liver disease
GBTC  Biliary tract cancer
EBD  Extrahepatic bile duct cancer
GB  Gallbladder
AmpV  Ampulla of Vater
EPIC  European Prospective Investigation into Cancer 
and Nutrition
ALT  Alanine aminotransferase
AST  Aspartate aminotransferase
GGT  Gamma-glutamyl tranferase
AP  Liver-specific alkaline phosphatase
BMI  Body mass index
Introduction
Primary liver cancers are comprised of hepatocellular 
cancer (HCC) and cancers of the intrahepatic bile ducts 
(IHBC) [1]. Together, they are the seventh most com-
mon cancer worldwide [2] and the third cause of death 
from cancer in both sexes [3]. HCC represents the major-
ity of primary liver cancers. Its risk factors include hepa-
titis B (HBV) and C (HCV) infections, aflatoxin exposure, 
tobacco smoking and heavy alcohol consumption mediated 
by liver cirrhosis [4, 5]. However, obesity, type 2 diabetes 
(T2D) and non-alcoholic fatty liver disease (NAFLD) could 
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also be contributing to the rising incidence of HCC [6–8]. A 
global increase has been also observed for the incidence of 
IHBC cancers, while for the extrahepatic bile duct (EBD) 
cancers, which are anatomically related to IHBC, there 
has been a decreasing trend worldwide [9]. The aetiology 
of IHBC cancer and cancers originating from biliary tract 
(GBTC), including: EBD, gallbladder (GB) and Ampulla 
of Vater (AmpV) cancers, is poorly understood. Obesity, 
diabetes mellitus, history of gallstones or cholecystitis have 
been proposed as possible risk factors for GBTC [8, 10].
Some dietary exposures may affect the development of 
cancers of the liver and biliary tract. For example, our own 
data from the European Prospective Investigation into Can-
cer and Nutrition (EPIC) cohort show that daily increase 
in sugar intake by 50 g was associated with a significantly 
higher risk of HCC, and non-significant positive associa-
tion with IHBC, but not GBTC [11]. Both soft drinks and 
some juices may contain high levels of sugars and could 
be related to HCC, IHBC or GBTC development directly 
or indirectly through associated diseases. Intake of soft 
drinks and fruit drinks has been linked to obesity, T2D and 
NAFLD [12–16]. It has also been shown that intake of soft 
drinks has increased progressively in the recent years. For 
example, in the USA, intake of sweetened beverages has 
increased by 60 % between 1977 and 2001 [17]. Also, an 
increase in prevalence of HCC and IHBC was observed in 
some developed countries; the annual incidence of HCC 
rose by 80 % in the last few decades [7]. Therefore, we 
hypothesise that intake of soft drinks and possibly juices 
could play a role in the development of HCC and maybe 
IHBC cancer.
To date, there have been no consensus in the literature 
regarding risk of various cancers and intake of soft drinks 
and/or juices [18–23], and associations for cancers of the 
liver and biliary tract have not been well studied. Given the 
rising consumption of sweetened non-alcoholic beverages 
and their likely link to several metabolic disorders that play 
a role in the development of these cancers, we present here 
an analysis of soft drinks and fruit and vegetable juices, 
in association with HCC, IHBC and GBTC in the EPIC 
cohort.
Subjects and methods
Study design
EPIC is a large prospective multicentre study that aims to 
investigate the relationship between nutrition and cancer, as 
well as other chronic diseases. The rationale, study popu-
lations and data collection have been described previously 
[24]. Over 520,000 participants were enrolled from 23 cen-
tres in Denmark, France, Greece, Germany, Italy, the Neth-
erlands, Norway, Spain, Sweden and the United Kingdom. 
Between 1992 and 1998, standardised lifestyle and personal 
history questionnaires, anthropometric data and blood sam-
ples were collected from most participants at recruitment, 
before disease onset or diagnosis. Blood samples are stored 
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at the International Agency for Research on Cancer (IARC, 
Lyon, France; −196 °C, liquid nitrogen) for all countries 
except Denmark (−150 °C, nitrogen vapour) and Sweden 
(−80 °C freezers) where they are stored locally. All cohort 
members provided written informed consent. Approval for 
this study was obtained from the relevant ethical review 
boards of the participating institutions and from the IARC 
ethical review board (Lyon, France) and have therefore 
been performed in accordance with the ethical standards 
laid down in the 1964 Declaration of Helsinki and its later 
amendments.
Case ascertainment
Overall, a total of 477,206 participants were included in 
this study after the following exclusions: 23,818 with prev-
alent cancer other than non-melanoma skin cancer, 4,380 
with incomplete follow-up data or missing information on 
the date of diagnosis, 6,192 with missing dietary informa-
tion, 60 with missing lifestyle information, and 9,596 those 
at the top or bottom 1 % of the distribution of the ratio of 
reported energy intake to energy requirement, and 78 with 
metastasis in the liver or ineligible histology code.
Cancer cases were identified using record linkage with 
regional cancer registries (Denmark, Italy, Netherlands, 
Norway, Spain, Sweden, UK; up to December 2006) or for 
France, Germany and Greece by health insurance records, 
contact with cancer or pathology registries or active follow-
up (up to June 2010). Cancer cases were defined according 
to the 10th revision of International Classification of Dis-
eases (ICD10): HCC (C22.0), IHBC (C22.1), GB (C23.9), 
AmpV (C24.1), EBD (C24.0, C24.8, C24.9). After a mean of 
11.4 person years of follow-up, 191 HCC, 66 IHBC and 236 
GBTC (87 GB, 54 AmpV, 95 EBD) cases were identified.
Dietary assessment and categories of intake
At enrolment, dietary intakes during the preceding 
12 months were assessed based on validated country-spe-
cific dietary questionnaires designed to ensure high compli-
ance and improved measures of local dietary habits [25]. 
Daily intakes of soft drinks and juices were determined in 
grams (g). Daily intakes of nutrients, alcohol and energy 
were calculated using standardised EPIC nutrient database 
[26]. The group of soft drinks included carbonated/soft/
isotonic drinks and diluted syrups. Further classification of 
soft drinks into sugar sweetened and artificially sweetened 
was possible for participants (n = 424,123) in all centres 
except three: Italy (North and Ragusa), Sweden (Umeå). 
The group of juices comprise fruit, citrus and/or vegetable 
juices (including fresh and commercial juices, and nectars, 
with possible addition of sugars up to 20 % of the total 
weight of the finished product [27]), but the classification 
by commercial and natural juices was not possible.
For the purposes of the present analysis, the intakes of 
soft drinks and juices were also categorised into servings, 
defined to reflect current European intake customs. A serv-
ing of soft drinks was defined here as 330 g, equivalent to 
a volume of a soft drink can size in Europe (330 mL). For 
juices, one serving was considered as 200 g, equivalent to 
regular glass (200 mL) in Europe considered as a standard 
portion size for juices [28].
Nested case–control study
A nested case–control study of these cancer sites was also 
conducted as previously described [11]. For each HCC, 
IHBC or GBTC case, two controls free of cancer (other 
than non-melanoma skin cancer) were selected from the 
cohort by incidence density sampling and matched by 
study centre, sex, age (±1 year) at the time (±2 months) 
and time of the day (±3 h) of blood collection, fasting 
status (<3, 3–6, >6 h); for women further for menopau-
sal status (pre-, peri-, post-menopausal), use of exogenous 
hormones (contraceptives or hormone replacement ther-
apy) at blood collection (yes/no). Between the recruitment 
and 2006, there were 125 HCC cases identified for which 
blood samples were available for laboratory measure-
ments. After the exclusion of cases and controls for whom 
laboratory measurements were not available due to miss-
ing sample or unsuccessful testing, the analyses included 
121 HCC cases and their 241 matched controls. Addition-
ally, the analyses were conducted for: 34 IHBC cases and 
their 67 controls, and 131 GBTC cases and 259 controls.
HBV and HCV status was assessed by measurement of 
the level of HBV surface antigen (HBsAg) or antibody to 
HCV (anti-HCV) with the use of relevant ARCHITECT 
chemiluminescent microparticle immunoassay (CMIA) 
(Abbott Diagnostics, France). Liver enzymes and other 
markers of liver function (alanine aminotransferase (ALT), 
aspartate aminotransferase (AST), gamma-glutamyl trans-
ferase (GGT), liver-specific alkaline phosphatase (AP), 
albumin, bilirubin) were measured on the ARCHITECT c 
Systems™ (Abbott Diagnostics) according to the manufac-
turer’s instructions. All laboratory analyses were performed 
by Centre de Biologie Republique Laboratory, Lyon, 
France.
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Statistical analyses
Cohort study
Comparisons of the baseline subject characteristics were 
done using the t test for continuous variables and the Chi-
square test for categorical variables. Sex-, age- and centre-
adjusted Pearson partial correlation coefficients were used 
to assess the correlations between dietary intakes of soft 
drinks (sugar sweetened and artificially sweetened) and 
juices and confounding factors in controls. Cox propor-
tional hazard models with age as a timescale (age at recruit-
ment and age of censoring or cancer diagnosis as entry and 
exit time, respectively) were used to calculate hazard ratio 
(HR) and 95 % confidence intervals (95 % CI) in order 
to estimate the association between soft drinks/juices and 
intakes and risks of HCC, IHBC, GBTC by defined catego-
ries, and as continuous variables (per number of servings a 
week) for all cancer and their subtypes.
In categorical analyses for both soft drinks and juices, 
non-consumers (reference category) were compared to 
either: (1) tertiles of intake among consumers, or (ii) cat-
egories of portions consumed per week: <1 (low consum-
ers), 1–6 (regular consumers), >6 (high consumers). In the 
centres with available information (all centres excluding 
Umea, north Italy and Ragusa), analyses were also con-
ducted stratified by sugar-sweetened and artificially sweet-
ened soft drinks. To test for linear trend, median values 
to each category of intake and 0 g/day for non-consumers 
were assigned and entered into regression models.
 Cox proportional hazards models were run as both 
crude (stratified by sex, age at recruitment in 1 year cat-
egories and study centre to account for differences in data 
collection, and adjusted for non-alcoholic energy intake 
using the standard method, i.e. by adding to the model 
[29]) and multivariable (additionally adjusted for a priori 
selected relevant confounders: smoking status and intensity 
of smoking (never; former smoker: quit <10 years ago, quit 
11–20 years ago, quit >20 years ago; Current smoker: 1–15 
cigarettes/day, 16–25 cigarettes/day, >25 cigarettes/day; 
other than cigarettes; current/former missing; unknown), 
alcohol intake at recruitment (g/day, continuous) and life-
time pattern of alcohol intake (never, former light, for-
mer heavy, light, never heavy, periodically heavy, always 
heavy drinkers, unknown); body mass index (BMI; kg/m2, 
continuous), sex-specific physical activity (inactive, mod-
erately active, active and missing), highest level of educa-
tion attained (as a proxy for socio-economic status; none/
primary, technical/professional, secondary, university or 
higher) and self-reported diabetes status (yes, no, miss-
ing)). Potential additional confounders considered but not 
included in the final model since they did not change the 
estimates by more than 10 % were: waist-to-hip ratio, level 
of intake of sugar from other sources other than sugar-
sweetened beverages, meats, fish, fruit and vegetables. The 
associations were also studied mutually adjusting both the 
crude and multivariable models for the other type of studied 
beverage (i.e. for soft drinks and juices, sugar-sweetened 
and artificially sweetened soft drinks), as well as other non-
alcoholic beverages intake; i.e. coffee and tea, since their 
intake may affect the intake of the beverages of interest or 
disease occurrence; however, they also did not appreciably 
modify the estimates and were not considered in the multi-
variable model. P for heterogeneity between estimates for 
individual exposures (i.e. soft drinks vs. juices and sugar-
sweetened vs. artificially sweetened soft drinks) was tested. 
The difference of these associations in relation to HCC was 
assessed by inspecting the significance of the parameter 
related to the arithmetic difference of the two exposures in 
a model that also included their arithmetic sum.
Cubic spline regression models were computed to vis-
ualise the shape of association between soft drinks and 
juices intake and HCC or GBTC risk, controlling for the 
same confounders as in the multivariable model. The 5 cut 
points (knots) for the soft drinks and juices intake were 
determined corresponding to 10th, 25th, 50th, 75th and 
90th percentile of intake expressed as number of servings 
(330-mL can, 200-mL glass) a week. For soft drinks that 
had more than 25 % non-consumers and therefore 10th and 
25th percentile were equal to 0, only 4 knots were assigned 
at the level of intake: 0.00, 0.19, 1.82 and 4.58 cans/week. 
For juices, 5 knots were fitted at 0.00, 0.03, 0.69, 3.30 and 
5.50 glasses a week. For better readability of the graph, 
the maximum was set as 99th percentile of intakes for soft 
drinks and juices (17.65 cans and 17.50 glasses a week, 
respectively).
Nested case–control subset
In the nested case–control study, odds ratio (OR) and 
95 % CI were computed by conditional logistic regres-
sion for HCC, IHBC, GBTC combined and their sub-
groups. For HCC, the OR (95 % CI) was also computed 
for subjects with HBV/HCV-negative infection status. 
Two analysis models were run for continuous intake per 
serving of soft drinks and juices: (1) conditioned on the 
matching factors only and adjusted for non-alcoholic 
energy intake (crude model) and (2) multivariable adjust-
ment for the same confounders as described for the cohort 
analyses. Because liver function may be altered in liver 
disease [30], the analyses per serving a week were also 
adjusted for liver function score (score: 0–6), based on 
the abnormal levels of liver function test (laboratory cut-
offs: ALT > 55 U/L, AST > 34 U/L, GGT > 64 UL-men 
and > 36 U/L-women, AP > 150 U/L, albumin < 35 g/L, 
total bilirubin > 20.5 µmol/L). Interaction between soft 
 Eur J Nutr
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Table 1  Baseline characteristics for HCC, IHBC and GBTC cases and non-cases
Number of persons with missing information: a  HCC = 4, IHBC = 4, EBD = 8, non-cases = 15,742
b
 HCC = 4, IHBC = 5, EBD = 8, non-cases = 16,906
c
 Self- reported; HCC = 15, IHBC = 13, EBD = 13, non-cases = 36,823
d
 Self-reported; HCC = 50, IHBC = 18, EBD = 76, non-cases = 145,718
e
 HCC = 9, IHBC = 5, EBD = 17, non-cases = 66,228
f
 HCC = 37, IHBC = 10, EBD = 60, non-cases = 113,950
g
 Sex-specific categories: light drinker (women: 0–3 g/day, men: 0–6 g/day); heavy drinker (women ≥30 g/day, men ≥60 g/day)
h
 Total energy exempting alcohol
HCC IHBC GBTC Non-cases
Sex
 Male [n (%)] 127 (66.5) 33 (50.0) 89 (37.7) 141,945 (29.8)
 Female [n (%)] 64 (33.5) 33 (50.0) 147 (62.3) 334,768 (70.2)
Age at recruitment (years) (mean ± SD) 59.6 ± 6.9 59.6 ± 7.7 58.1 ± 8.1 51.2 ± 9.9
BMI (kg/m2) (mean ± SD) 28.0 ± 4.8 27.0 ± 4.2 26.6 ± 4.5 25.4 ± 4.3
Waist-to-hip ratio (mean ± SD) 0.94 ± 0.10 0.90 ± 0.10 0.87 0.10 0.84 ± 0.10
Smoking status, duration and intensitya [n (%)]
 Never smoker 53 (27.7) 28 (42.4) 110 (46.6) 205,157 (43.0)
 Current smoker, occasional 14 (7.3) 3 (4.5) 11 (4.7) 40,046 (8.4)
 Current smoker, 1–15 cigarettes/day 23 (12.0) 6 (9.0) 26 (11.0) 55,258 (11.6)
 Current smoker, 16–25 cigarettes/day 24 (12.6) 4 (6.1) 17 (7.2) 29,822 (6.3)
 Current smoker, > 25 cigarettes/day 14 (7.3) 1 (1.5) 5 (2.1) 8,647 (1.8)
 Former smoker, quit ≤ 10 years ago 17 (8.9) 3 (4.5) 15 (6.4) 45,552 (9.6)
 Former smoker, quit 11–20 years ago 18 (9.4) 9 (13.6) 29 (12.3) 38,923 (8.2)
 Former smoker, quit > 20 years ago 24 (12.6) 8 (12.1) 15 (6.4) 37,566 (7.9)
Highest level of education attainedb [n (%)]
 None 12(6.3) 3 (4.5) 12 (5.1) 20,909 (4.4)
 Primary or secondary school 141 (73.8) 47 (71.2) 175(74.2) 325,492 (68.3)
 University or higher 34 (17.8) 11 (16.7) 41 (17.4) 113,406 (23.8)
No. with diabetes at baselinec [n (%)] 22 (11.5) 2 (3.0) 16 (6.8) 12,478 (2.6)
No. with gallstones at baselined [n (%)] 21 (11.0) 15 (22.7) 30 (12.7) 24,473 (5.1)
Physical activitye [n (%)]
 Inactive 18 (9.4) 8 (12.1) 29 1(2.3) 71,709 (15.0)
 Moderately inactive 68 (35.6) 20 (30.3) 76 (32.2) 142,918 (30.0)
 Moderately active 78 (40.8) 28 (42.4) 92 (39.0) 156,660 (32.9)
 Active 18 (9.4) 5 (7.6) 22 (9.3) 39,198 (8.2)
Alcohol intake lifetime patternf, g [n (%)]
 Never drinkers 8 (4.2) 3 (4.5) 12 (5.1) 28,136 (5.9)
 Former light drinkers 12 (6.3) 6 (9.1) 9 (3.8) 15,030 (3.2)
 Former heavy drinkers 10 (5.2) 2 (3.0) 3 (1.3) 1,979 (0.4)
 Light drinkers 23 (12.0) 10 (15.2) 39 (16.5) 87,806 (18.4)
 Never heavy drinkers 63 (33.0) 25 (37.9) 94 (39.8) 184,436 (38.7)
 Periodically heavy drinkers 32 (16.8) 9 (13.6) 17 (7.2) 42,408 (8.9)
 Always heavy drinkers 6 (3.1) 1 (1.5) 2 (0.8) 2,968 (0.6)
Alcohol at baseline (g/day) 20.3 ± 31.6 13.5 ± 18.4 11.9 ± 16.9 11.6 ± 16.8
Dietary intakes (mean ± SD)
 Soft drinks (g/day) 129.8 ± 280.3 66.1 ± 155.1 51.7 ± 113.9 76.8 ± 166.3
 Juices (g/day) 78.0 ± 150.9 93.9 ± 134.6 58.8 ± 95.7 63.7 ± 108.9
 Sugar (g/day) 108.6 ± 51.5 113.4 ± 46.8 99.4 ± 41.3 102.9 ± 43.8
 Total energyh (kcal/day) 2,034.9 ± 647.3 2,069.1 ± 649.8 1,965.5 ± 595.9 1,990.5 ± 590.4
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drinks and juices intake and liver function score catego-
ries (no damage 0, possible damage 1–6), as well as BMI 
categories (BMI: <25 kg/m2 normal weight, ≥25–30 kg/
m2 overweight, ≥30 kg/m2 obese) was also studied. 
Where the interaction appeared significant, multivariable 
logistic regression additionally adjusted for matching cri-
teria was run for the individual subgroups within the cat-
egories for the cancer risk and intake of soft drinks and 
juices.
Sensitivity analyses and effect modification
In sensitivity analyses, the analyses were repeated exclud-
ing: (1) cases diagnosed prior to 2 years of follow-up in 
order to exclude for potential reverse-causation, (2) partici-
pants with self-reported diabetes at baseline due to possible 
diet modifications and (3) consumers with extreme intakes 
(the highest percentile).
Interaction between soft drinks and juices intake and 
sex, BMI and alcohol intake patterns was studied to con-
sider potential effect modification. The statistical signifi-
cance of associations was based on likelihood ratio tests on 
the models with and without interaction terms. All statisti-
cal analyses were performed with SAS 9.2 and considered 
statistically significant if p < 0.05.
Results
Participants and their lifestyle and diet
Participants who developed HCC were mainly men, older, 
physically active, less educated, and were more likely to have 
prevalent diabetes and gallstones, to be current smokers, and 
to be former or current heavy drinkers than the non-cases. 
They also had higher BMI and waist-to-hip ratio. IHBC 
Table 2  HR (95 % CI) for HCC by categories of soft drink and juice consumption compared to non-consumers in the EPIC cohort
a
 Crude Model: Cox proportional hazard model adjusted for non-alcoholic energy intake and stratified by age (1-year intervals), sex and study 
centre. P for linear trend was computed by assigning median values to each category of consumers and 0 g/day for non-consumers
b
 Multivariable Model: additionally adjusted for BMI, sex-specific physical activity, education level, alcohol at recruitment and alcohol intake 
pattern, smoking intensity, duration and history, diabetes status
c
 Can volume 330 mL, glass volume 200 mL
d
 In reference to non-consumers
e
 p = 0.57 for heterogeneity for associations for drinks and juices with HCC
PY Cases Median intake
(5, 95 %) (g/day)
Crude Modela Multivariable Modelb
Soft drinks
 Non-consumers 2,044,390 78 0.0 (0.0, 0.0) Reference Reference
 Tertile 1 1,058,798 30 6.7 (1.4, 23.0) 0.73 (0.47, 1.15) 0.82 (0.52, 1.29)
 Tertile 2 1,097,448 31 50 (28.6, 103.5) 0.84 (0.53, 1.31) 0.94 (0.60, 1.48)
 Tertile 3 1,061,657 52 216.8 (114.3, 827.0) 1.47 (1.00, 2.16) 1.46 (0.99, 2.16)
 Ptrend <0.01 0.01
 <1 canc,d/week 1,556,294 44 16.4 (1.4, 42.9) 0.79 (0.53, 1.19) 0.90 (0.60, 1.34)
 1–6 cans/week 1,288,584 45 112.5 (50.7, 254.0) 0.98 (0.65, 1.46) 1.05 (0.70,1.57)
 >6 cans/week 373,026 24 500 (295.2, 1155.6) 1.94 (1.19, 3.16) 1.83 (1.11, 3.02)
 Ptrend <0.01 0.01
 Per can/weeke 1.06 (1.03, 1.08) 1.05 (1.02, 1.07)
Juices
 Non-consumers 1,137,774 51 0.0 (0.0, 0.0) Reference Reference
 Tertile 1 1,391,106 49 6.6 (0.1, 15.7) 0.52 (0.32, 0.92) 0.57 (0.35, 0.92)
 Tertile 2 1,396,782 41 42.9 (17.1, 78.6) 0.63 (0.39, 1.02) 0.77 (0.48, 1.25)
 Tertile 3 1,336,632 50 142.0 (94.3, 452.6) 0.84 (0.53, 1.33) 0.98 (0.62, 1.55)
 Ptrend 0.31 0.15
 <1 glassc,d/week 1,771,163 60 8.4 (0.3, 25.8) 0.54 (0.34, 0.85) 0.60 (0.38, 0.95)
 1–6 glasses/week 1,875,327 52 76.8 (35.4, 450.0) 0.62 (0.39, 0.97) 0.75 (0.48, 1.18)
 >6 glasses/week 478,030 28 273.8 (179.7, 650.5) 1.24 (0.72, 2.15) 1.38 (0.80, 2.38)
 Ptrend 0.03 0.02
 Per glass/weeke 1.03 (1.01, 1.06) 1.03 (1.01, 1.06)
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cases were equally distributed between the sexes and older 
then the non-cases and a higher proportion of them reported 
gallstones. Participants who developed GBTC were mostly 
women, less educated and were more likely to have diabetes 
and gallstones at baseline as compared to non-cases (Table 1).
Both daily consumers of soft drinks and juices were 
characterised by less healthy dietary pattern than non-
consumers (higher consumption of sugar and confection-
ary, cakes and biscuits, and lower intake of legumes, fruits 
and vegetables, fish and shellfish), which was reflected in 
their higher intake of sugar (30 %), fat (5–6 %) and energy 
(10 %) (Online Resource 1). Self-reported diabetic subjects 
were more likely to consume daily artificially than sugar-
sweetened soft drinks (5.5 vs. 1.9 %, respectively). In com-
parison, more non-diabetics consumed sugar-sweetened 
(2.8 %) than artificially sweetened soft drinks (1.6 %). Sim-
ilar trend was observed for BMI categories; 4 % of obese 
subjects consumed daily artificially sweetened drinks vs. 
1.6 % of those with normal weight. For sugar-sweetened 
drinks, the proportion was distributed equally between the 
BMI groups at the level of 3 %. Intake of soft drinks and 
juices positively correlated with dietary sugar (r = 0.28 and 
0.34) and energy (r = 0.10 and 0.10). Similar coefficients 
were observed for sugar-sweetened group of soft drinks 
(rsugar = 0.33 and renergy = 0.10), but no correlation with 
these variables existed for artificially sweetened drinks. 
No correlation was observed between any type of the bev-
erages and BMI, waist-to-hip ratio, physical activity level 
and alcohol intake at recruitment.
Soft drink intake and the risk of HCC
Compared to non-consumers, the highest tertile of soft 
drinks consumers showed a borderline significant higher 
risk of HCC after adjustment for confounders (HR 1.46, 
95 % CI 0.99–2.16; ptrend = 0.01), and no significant asso-
ciations were observed for the first and the second tertile of 
consumers (Table 2).
Consumption of more than six (6 × 330 mL) cans per 
week of soft drinks was significantly associated with higher 
risk of HCC after adjustment for confounders, as com-
pared to non-consumers (HR 1.83, 95 % CI 1.11–3.02; 
ptrend = 0.01); no significant associations were observed for 
lower intakes (Table 2).
In continuous analyses, the increment of 330 mL of soft 
drinks a week was significantly positively associated with 
the risk of HCC after adjustment for confounders (HR 1.05, 
95 % CI 1.02–1.07) (Table 2). Spline regression analyses 
by an increase in a serving a week showed a linear mostly 
positive association with HCC that appeared significant for 
daily and higher consumption of soft drinks (Fig. 1a).
In additional analyses by the type of drinks (sugar-sweet-
ened vs. artificially sweetened), each additional serving of 
artificially sweetened soft drink was positively associated 
with HCC risk (HR 1.06, 95 % CI 1.03–1.09, ncases = 101), 
while for sugar-sweetened soft drinks, this association was 
null (HR 1.00, 95 % CI 0.95–1.06, ncases = 127). The dif-
ference between both estimates was borderline significant 
(pheterogeneity = 0.07).
Juice intake and the risk of HCC
Compared to non-consumers, the lowest tertile of juice 
intake was significantly associated with reduced HCC risk 
in both crude (HR 0.52, 95 % CI 0.32–0.92; ptrend = 0.31) 
and multivariable models (HR 0.57, 95 % CI 0.35–0.92; 
ptrend = 0.15), while no significant association was observed 
for the second and third tertile of consumers (Table 2).
HR
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b
Fig. 1  Spline regression models for the intake of soft drinks (a) and 
juices (b) in relation hepatocellular carcinoma risk. Reference 0 mL/
week. Knots correspond to 10th, 25th, 50th, 75th and 90th percentile 
of intake. The maximum corresponds to the 99th percentile. Solid 
lines- HR, dashed lines- 95 % CI
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When considering intake as serving categories in rela-
tion to non-consumers, consumption of less than a 200-
mL glass a week was associated with lower HCC risk 
in multivariable model (HR 0.60, 95 % CI 0.38–0.95; 
ptrend = 0.02), and when only consumers were considered, 
a positive trend (ptrend = 0.004) was observed for higher 
consumption. The highest category of intake was non-sig-
nificantly positively associated with HCC risk (HR 1.38, 
95 % CI 0.80–2.38; ptrend = 0.02) (Table 2).
In continuous analyses, the increase in intake of one 
serving (200 mL) of juice a week was positively associ-
ated with the risk of HCC (HR 1.03, 95 % CI 1.01–1.06) 
(Table 2). In spline regression analyses, the association for 
juices was negative and significant only for intakes lower 
than one glass a week (Fig. 1b).
Sensitivity analyses and effect modification for HCC risk 
and soft drinks and juices intake
Exclusion of persons diagnosed with HCC within the first 
2 years from recruitment did not change the findings for 
either exposure (data not shown). When only non-diabetic 
individuals were studied, the HRs were similar to whole 
cohort estimates, but weaker, probably due to lower sample 
size of this sub-cohort. Excluding participants with the 1 % 
highest intakes of soft drinks and juices did not modify the 
results for juices, but the association for the highest tertile 
for soft drinks was attenuated (HR 1.35, 95 % CI 0.87–2.10).
No statistically significant interactions were observed 
between categories of soft drink intake and sex 
(p = 0.200), BMI category (p = 0.126) or alcohol intake 
pattern (p = 0.912) nor categories of juices intake and sex 
(p = 0.568), BMI category (p = 0.617) or alcohol intake 
pattern (p = 0.745).
Table 3  Hazard ratios and 95 % CI for IHBC and GBTC and its subsites associated with one serving increment per week in the consumption of 
soft drinks and juices in the EPIC cohort
Serving for soft drinks corresponds to 330 mL and for juices to 200 mL
IHBC intrahepatic bile duct, GBTC biliary track, EBD extrahepatic bile duct, GB gallbladder, AmpV Ampulla of Vater cancers
a
 Crude Model adjusted for non-alcoholic energy intake and stratified by age(1-year intervals), sex and study centre
b
 Multivariable Model: additionally adjusted for BMI, sex-specific physical activity, education level, alcohol at recruitment and alcohol intake 
pattern, smoking intensity, duration and history, diabetes status (IHBC) and gallstones history (GBTC and their subtypes)
IHBC (N = 66)
HR (95 % CI)
GBTC All GBTC (N = 236)
HR (95 % CI)
EBD (N = 95)
HR (95 % CI)
GB (N = 87)
HR (95 % CI)
AmpV (N = 54)
HR (95 % CI)
Soft drinks
 Crudea 0.99 (0.91, 1.07) 0.95 (0.86, 1.04) 0.91 (0.80, 1.03) 1.02 (0.95, 1.10) 0.96 (0.91, 1.00)
 Multivariableb 0.97 (0.90, 1.06) 0.94 (0.86, 1.03) 0.89 (0.79, 1.01) 1.02 (0.95, 1.10) 0.96 (0.90, 1.00)
Juices
 Crude 1.04 (1.00, 1.08) 1.01 (0.96, 1.06) 0.97 (0.91, 1.04) 0.97 (0.87, 1.08) 0.99 (0.95, 1.03)
 Multivariable 1.04 (1.00, 1.08) 1.01 (0.96, 1.06) 0.97 (0.91, 1.04) 0.97 (0.88, 1.08) 0.99 (0.95, 1.03)
Table 4  OR and 95 % CI for HCC associated with one serving incre-
ment per week in the consumption of soft drinks and juices in the 
nested case–control study within the EPIC cohort
Serving for soft drinks corresponds to 330 mL and for juices to 
200 mL
a
 Crude Model: matching factors only and adjusted for non-alcoholic 
energy intake
b
 Multivariable Model: crude model additionally adjusted for BMI, 
sex-specific physical activity, education level, alcohol at recruitment 
and alcohol intake pattern, smoking intensity, duration and history, 
diabetes status
c
 Liver function score (1–6) was calculated according to the cut-
off values for: ALT > 55 U/L, AST > 34 U/L, GGT > 64 UL-men 
and 36 U/L-women, AP > 150 U/L, albumin < 35 g/L, total biliru-
bin > 20.5 µmol/L
Cases Controls OR (95 % CI)
Soft drinks
 Crude Modela 121 241 1.21 (1.09, 1.35)
 Multivariable Modelb 1.18 (1.04, 1.34)
 Multivariable Model + liver 
function score
1.22 (1.05, 1.40)
 Multivariable Model + hepatitis 
statusc
1.19 (1.04, 1.37)
 Multivariable model for 
hepatitis-free individuals
84 162 1.22 (1.04, 1.44)
Juices
 Crude Model 121 241 1.03 (0.97, 1.09)
 Multivariable Model 1.01 (0.93, 1.09)
 Multivariable Model + liver 
function score
1.04 (0.95, 1.13)
 Multivariable Model + hepatitis 
status
0.99 (0.90, 1.08)
 Multivariable model for 
hepatitis-free individuals
84 162 1.00 (0.90, 1.12)
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Intake of juices and soft drinks and the risk of IHBC, 
GBTC and its subtypes
The risk of IHBC in an adjusted model per 200 mL increase 
in juice intake a week was higher by 4 % (HR 1.04, 95 % 
CI 1.00–1.08). The increment of a serving of soft drink or 
juice a week was not significantly associated with GBTC 
subtypes (Table 3).
No significant associations were observed for ter-
tiles of soft drinks or juices consumers in relation to non-
consumers and the risk of GBTC. Also, when the intakes 
were treated as serving categories of soft drinks compared 
to non-consumers, no associations were found (data not 
shown). For each additional 330 mL of soft drink a week, a 
borderline inverse association was observed with all GBTC 
combined (HR 0.96, 95 % CI: 0.91–1.00). A mostly nega-
tive, although not significant, association was observed 
based on cubic splines for soft drinks or juice and GBTC 
risk (data not shown).
Nested case–control study
In a nested case–control subset, each additional can of soft 
drink a week increased the risk of HCC (OR 1.18, 95 % CI 
1.04–1.34). These results were maintained in hepatitis-free 
individuals or after adjustment for hepatitis status or liver 
function score (Table 4). There was no significant associa-
tion for soft drinks and the risk of IHBC or GBTC (data not 
shown).
For HCC, an interaction was observed between increase 
in one portion of soft drink intake and liver function score 
category (p = 0.028). Stratified analyses by liver func-
tion score category revealed a significantly higher risk 
of HCC by soft drink intake in the suggested liver dam-
age subgroup (score 1–6) (OR 1.46, 95 % CI 1.04–2.03), 
while in the group with no liver damage, this association 
was not significant (OR 1.15, 95 % CI 0.87–1.51) (data 
not shown). There was no interaction between soft drink 
intake and either BMI (p = 0.296) or alcohol intake pattern 
(p = 0.362).
Drinking an additional glass of juice a week was not 
associated with HCC risk (OR 1.00, 95 % CI 0.93–1.08) 
(Table 4). There was no significant association for juices 
and the risk of IHBC or GBTC (data not shown). No inter-
action was observed between juice intake and liver func-
tion score (p = 0.862), alcohol intake pattern (p = 0.055) 
or BMI category (p = 0.195).
Discussion
There was a positive association between consumption of 
soft drinks and HCC risk, which was present in continuous 
analyses and for the highest categories of intake in the 
cohort, but also in the nested case–control subset after 
adjustment for hepatitis status and liver function score. 
In subgroup analyses by soft drink category, per serving 
increase in artificially sweetened but not sugar-sweetened 
soft drinks, this association was significant. Each increment 
of a serving of soft drink was associated with lower overall 
GBTC risk, but no significant associations were observed 
when the intakes were treated as categories. No significant 
associations existed in the cohort for regular or high juice 
consumers and risk of HCC. Compared to non-consumers, 
an intake of up to one serving of juice per week was associ-
ated with an inverse HCC risk, but for each additional serv-
ing of juice, there was a positive association with HCC and 
IHBC risk.
Previously reported findings from the EPIC cohort have 
shown that high sugar intakes are positively significantly 
associated with HCC risk and not significantly with IHBC, 
but inversely associated with GBTC [11]. Soft drinks con-
tain 55–130 g of total sugar per litre [31]. However, most 
commercial and some natural fruit juices may also be 
characterised by high sugar levels, i.e. 3–112 g/L [32]. 
Therefore, we hypothesised that intakes of high in sugar 
beverages may be linked to development of HCC and pos-
sibly IHBC. In this study, only soft drinks showed a posi-
tive association with HCC, but we could not distinguish 
between commercial and natural juices. The observed link 
between intake of soft drinks and HCC could be mediated 
through some conditions associated with HCC, such as 
obesity [33, 34]. In observational studies, positive associa-
tion for soft drinks intake and obesity is mainly observed 
for extreme categories of intake [35]. In this study, a posi-
tive association with HCC exists only for high soft drinks 
consumers, but interestingly BMI did not appear as an 
important confounder for this association; addition of BMI 
to the model did not considerably modify the risk esti-
mates, and no interaction was observed between BMI cat-
egories and intakes of combined soft drinks.
Higher risk of HCC in daily consumers of soft drinks 
could be also related to adverse effects of their high sugar 
content on lipid and glucose metabolism [36]. Soft drinks, 
high in both glucose and fructose, result in a rapid increase 
in blood glucose and insulin levels at the intermediate 
level between the responses observed for pure glucose and 
fructose [37]. Fructose is rapidly taken up by the liver and 
favours de novo lipogenesis which may lead to hepatic 
lipid accumulation and finally to NAFLD [38]. Soft drink 
intake was significantly associated with an increased risk 
for NAFLD [39]. Taking into account that nearly three 
quarters of patients infected with HCV and half of HBV 
positive patients exhibit liver steatosis, of which 10–20 % 
develop NAFLD [40], we repeated the analysis in a case–
control subset excluding hepatitis positive individuals and 
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additionally adjusting for liver function score, an indica-
tor of liver dysfunction. We found that each increment of a 
portion of soft drink was associated with increased risk of 
HCC by 20 %, independently of hepatitis status. However, 
observed interaction between liver function score and soft 
drink intake in relation to HCC risk may indicate that liver 
damage may play a role in HCC development associated 
with soft drinks intake.
Interestingly, when we investigated these associations 
further, after categorising soft drinks into sugar sweetened 
and artificially sweetened in the subset of centres where 
this data were available (91 % of the cohort), only for the 
artificially sweetened soft drinks, the association was posi-
tive. Similar findings were previously reported in the EPIC 
cohort and its French sub-cohort for the association between 
soft drinks and juices and diabetes risk; 350 mL increment 
of artificially sweetened soft drink had stronger effect on 
increased risk of developing diabetes than sugar-sweetened 
soft drink, while juice intake was not associated with diabe-
tes [8, 41]. Indeed, a recent study in mice reported an effect 
of non-caloric artificial sweeteners on intestinal micro-
biota composition leading to induction of glucose intoler-
ance [42], but the findings require further confirmation in 
humans. Diabetes could be another important intermediate 
factor between HCC risk and soft drinks consumption. The 
intake of soft and fruit drinks is associated with increased 
risk of T2D [12, 35]. This may imply that: (1) components 
other than sugar present in diet/reduced-sugar soft drinks, 
such as sweetening agent or colourants, could be associated 
with the risk of HCC; (2) artificially sweetened beverages, 
in general considered as healthier since they do not contain 
sugar, could be more frequently consumed by individuals 
with some existing underlying disorders, for example dia-
betes or obesity, and (3) diabetes/obesity might have been 
a consequence of high intake of sugary drinks in the past. 
Indeed in our cohort, self-reported diabetic subjects or 
obese individuals consumed daily more frequently artifi-
cially sweetened than sugar-sweetened soft drinks.
It can also be hypothesised that the group of high con-
sumers of soft drinks would be characterised by less 
healthy dietary pattern. Data from an American dietary 
survey 1999–2002 indicated that soft drinks are more fre-
quently consumed in the fast food dietary cluster, but less 
often by individuals characterised by a diet high in vegeta-
bles [43]. In this study, high consumers of both soft drinks 
and juices had less healthy dietary intakes and higher alco-
hol, sugar and energy content of their diet. The adjustment 
for some food components that may affect risk of liver and 
biliary track cancers (e.g. intake of meat, fish, fruit and 
vegetables) did not modify the outcomes, but we cannot 
rule out a confounding effect of other dietary components.
The nature of the association between juice and HCC 
risk may also vary according to different thresholds of 
intake. Juices are considered as healthier dietary choices 
due to their antioxidant, minerals, vitamins, phytochemi-
cals and fibre content [44], as compared to soft drinks with 
poor nutritional quality. Fibre and polyphenols are known 
for their protective role against cancers in different sites 
[45], including HCC [11, 46]. Our results may suggest 
that at lower consumption, the beneficent effect of some 
juice components is present, whereas at very high levels of 
consumption, the sugar content of juices may override the 
potentially protective role of other components of juices. 
This could be supported by the observation that when only 
consumers were considered, increasing risk of HCC was 
observed with higher category of intake.
Strengths of the present study include its prospective 
multicentre design that included a diverse European popu-
lation with different habits of drinks and juices intakes [47]. 
Availability of detailed lifestyle and health status informa-
tion made it possible to control for multiple confounders. 
Additionally, biochemical measurements of hepatitis status 
and liver enzymes enabled to control for the key risk fac-
tors for HCC. We were able to distinguish between multi-
ple morphologic sites of liver and biliary tract cancers.
The study has some limitations. Liver and biliary tract 
cancers are relatively rare; a small sample size was avail-
able for analysis. The dietary and lifestyle data were col-
lected only at baseline; it is possible that participants modi-
fied their dietary intakes during the follow-up. To control 
for potential diet modification, we conducted sensitivity 
analyses excluding cases identified within the first two 
years of follow-up. We were not able to distinguish between 
different kinds of juice (e.g. natural juices or nectars with 
added sugar) as well as the type of sugar or sweetener in 
the beverages, which made it difficult to assess the effect 
of added sugar or type of artificial sweetener used on the 
diet–disease relationship. Given the small study size which 
is even further reduced in the subgroup analyses, it is pos-
sible that these results were obtained by chance. So, con-
firmation from other settings and populations is necessary.
In conclusion, our results indicate that high consump-
tion (one or more cans a day) of all combined soft drinks 
may increase the risk of HCC, but not GBTC. Interest-
ingly, this association was mainly driven by the subgroup 
of artificially sweetened soft drinks. A modest consumption 
of juices may be associated with a lower risk of HCC, but 
this effect disappears at higher levels of consumption. The 
findings could be important for public health concerning 
dietary recommendations in cancer prevention. However, 
more research is required to determine whether the obser-
vations presented here are indeed real, and whether they 
are related directly to higher sugar intake, higher intake of 
artificial sweeteners or to other dietary or lifestyle patterns 
or HCC-associated disease status associated with consump-
tion of soft drinks and juices.
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